clevidipine has been researched along with amodiaquine in 1 studies
Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (amodiaquine) | Trials (amodiaquine) | Recent Studies (post-2010) (amodiaquine) |
---|---|---|---|---|---|
127 | 19 | 62 | 1,455 | 315 | 473 |
Protein | Taxonomy | clevidipine (IC50) | amodiaquine (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 4.7 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 5.15 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.99 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 0.99 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for clevidipine and amodiaquine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |